Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Antengene Presented First Preclinical Data at EULAR 2026 Showing ATG-207 Promotes Regulatory T Cell Induction and Immune Tolerance
-
GNI Group to Acquire Ayumi Pharmaceutical Holdings, Expanding Its Position as a Global Biopharmaceutical Company
-
Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: Announces Upcoming EAI Robotics Major Launch Events in June, Along with the First Cooperation Agreement with U.S. K-12 Publi
-
LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China
-
Odysight.ai® Establishes At-The-Market (ATM) Program of up to $20 Million to Enhance Financial Flexibility
-
NAVER Expands AI Infrastructure With NVIDIA to Serve Surging Global AI Demand
-
NVIDIA and SK hynix Announce Multiyear Technology Partnership to Advance Memory for AI Factories
-
SK Telecom and NVIDIA Build AI Infrastructure to Power Korea’s AI Innovation
-
Entrata Collaborates with OpenAI to Define the Future of Autonomous Property Management
-
VolitionRx Announces Pricing of $4.6 Million Public Offering
-
Philippine Ifugao Artifacts to Be Featured at the June 12, 2026, Grand Opening of The Filipino American Museum in Las Vegas
-
Christina Taft Connects Monaco-Inspired Vision Rooted in Elegance and Purpose
-
Novo Nordisk's CagriSema 2.4 mg / 2.4 mg demonstrated significant reduction in HbA1c and weight across multiple studies in the REIMAGINE program presented at ADA 2026
-
Once-Weekly CagriSema (Amylin-Semaglutide) Combination Injection More Effective than Standalone Medications
-
Diasome Presents Phase 2b Data Demonstrating HDV™-Insulin Lispro Maintains Glycemic Control While Reducing Hypoglycemia in Adults with Type 1 Diabetes
-
Best Crypto To Buy Now: Hyperliquid Revenue Buzz Meets Zcash Fear as AlphaPepe Pushes Product Proof
-
XRP Price Prediction: XRP Stalls Near $1.12 While MemeToro Demonstrates Real AI Trading Utility
-
AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS
-
Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes
-
Canadian Employers Invited to Create 10,000 New Opportunities Through National Inclusive Hiring Campaign
-
GoHealth, Inc. to strengthen its position ahead of AEP 2026 through Restructuring Process supported by key stakeholders
-
Seven Ways to Get Featured on Yahoo Finance in Twenty Twenty Six
-
Pepe Coin Price Prediction: PEPE’s 2026 Upside Looks Limited While MemeToro Expands Real AI Utility for Traders
-
BNB Price Prediction: $585 Support Holds as ETF Speculation and MemeToro’s AI Ecosystem Fuel Market Interest
-
Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health
-
Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss
-
Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide
-
Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in p
-
Boehringer Ingelheim’s survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved metabolic
-
Global Electrification, Critical Minerals and EV Innovation: A Long-Term Vision for Investors Following the Evolution of Lithium, Rare Earths and Emerging Technologies
-
Global Demand for Lithium, Rare Earth Minerals, and EV Technology Continues To Grow
-
Butler County Jury Returns $12.5 Million Verdict Against Chesterwood Village, Including Punitive Damages, in Wrongful Death of 83-Year-Old Resident
-
Investors Worldwide Are Discovering New Opportunities In Lithium, Rare Earth Minerals, and EV Technology
-
Antag Therapeutics presents positive Phase 1 results at the 2026 Scientific Sessions of the American Diabetes Association for AT7687, a first-in-class GIPR antagonist
-
Avax Price Prediction: AVAX Fights $6.79 Support as MemeToro Gains Momentum Across AI Trading Discussions
-
Million Securities: Guided by Compliance as a Lighthouse, Shielded by Security as a Bulwark Building the Trust Cornerstone of a "Shared Interests" Ecosystem
-
Billionaires, Millionaires, Microcap and Penny Stock Investors: The Global Race for Lithium, Rare Earth Minerals and EV Technology Is Accelerating
-
CREDIT AGRICOLE S.A. ANNOUNCES REDEMPTION OF ¥84,200,000,000 Japanese Yen Callable Senior Non-Preferred Bonds issued on June 3, 2021 (ISIN: JP525022AM69)
-
Megafurniture.sg Brings Furniture Manufacturing In-House With New Factories in Batu Pahat and Foshan, Producing Mattresses, Sofas and Bed Frames
-
Rich Chef Poor Chef Named Best Business Book in Hospitality and Career Category in the United States for 2026
-
Liplyn Group Brings International News Outlets and Job Platforms Together Under the Drimble Brand
-
DM Force Sets the Pace for Real Estate Investors Navigating the AI Shift
-
5 Best Crypto Presales to Watch as Crypto Fear Spikes and Retail Hunts the Next Recovery Trade
-
Landless Theatre Company Presents EVIL LIBRARIAN: A New Musical in Washington, DC
-
VERDO's Independent Operations Reshape the Global Micromobility Landscape and Usher in a New Era of Shared Mobility
-
Ethereum Price Prediction: ETH Eyes $2,000 Recovery Talk as MemeToro Builds a Smaller-Cap AI Utility Narrative
-
Jake Sweeney Chevrolet Highlights Commercial Vehicle Solutions for Cincinnati-Area Businesses
-
Jake Sweeney Used Car Superstore Highlights Affordable Bargain Inventory for Cincinnati-Area Drivers
-
Leif Johnson Ford of Manor Expands Commercial Vehicle Inventory with New Work Trucks Designed for Growing Texas Businesses
-
Basil Resale Highlights Used and Certified Pre-Owned Vehicle Inventory Priced Under $20,000
